India's Aurobindo Pharma's quarterly profit rises by a third on strong US demand

Nov 4 (Reuters) - Indian drugmaker Aurobindo Pharma (ARBN.NS), opens new tab reported a nearly 33% rise in second-quarter profit on Wednesday, led by strong demand and volume gains in its US market.

Here are more details:

($1 = 94.7100 Indian rupees)

Reporting by Kashish Tandon and Anushka Rajvedi in Bengaluru; Editing by Sahal Muhammed